Posts Tagged ‘whitepaper’

New Whitepaper Helps with Selection of ICP-OES Spectrometer’s Plasma Interface: Axial-View, Radial-View, Dual-View or New Multiview

Kleve, February 4, 2015— A new whitepaper helps purchasers of new ICP-OESspectrometers through the critical — and complex — process of selecting the best appropriate plasma viewing interface for their intended applications. The paper is available to download from SPECTRO Analytical Instruments at http://goo.gl/VuH6qA.

The new whitepaper, “Selecting Your ICP-OES Analyzer’s Plasma Interface: Axial-View, Radial-View, Dual-View or New MultiView,” recommends that when considering a new ICP-OES analyzer purchase, users should focus their selection of the plasma interface based on the range of their applications and the elements they expect to analyze. Doing so, and understanding the benefits and drawbacks of each available viewing technology — axial-view, radial-view, dual-view, or MultiView — will help determine which is the best fit for their analytical tasks. In the whitepaper, each of the differing plasma viewing technologies are defined, their strengths and weaknesses are highlighted, and examples of typical applications are provided.

The paper also discusses a recent development in plasma viewing techniques — the sequential MultiView technology — that transcends the various disadvantages of the “dual-view” approach by eliminating the use of added mirrors or periscopes. Instead, the MultiView solution enables the user to simply shift the direction of the plasma torch into a new axial or radial orientation with a relatively simple changeover that takes about 90 seconds. As a result, MultiView offers full axial sensitivity and full radial precision without any dual-view compromises — for the functional equivalent of two dedicated, fully optimized analyzers in one. The new technology is currently available in one version of the new SPECTRO ARCOS analyzer — making the spectrometer the only ICP-OES instrument that offers both axial and radial plasma views, but without bias or compromise.

SPECTRO, a unit of the Materials Analysis Division of AMETEK, Inc., manufactures advanced instruments, develops the best solutions for elemental analysis for a broad range of applications, and provides exemplary customer service. SPECTRO’s products are known for their superior technical capabilities that deliver measureable benefits to the customer. From its foundation in 1979 until today, more than 30,000 analytical instruments have been delivered to customers around the world.

AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical products with over 15,000 colleagues at more than 120 manufacturing and sales and service operations in the United States and 30 other countries around the world.

Kleve, November 20, 2014 — A new whitepaper detailing how new ICP-OES spectrometer technologies are substantially cutting operating costs in environmental, industrial, and academic is available to download from SPECTRO Analytical Instruments at http://icp-oes.spectro.com/blue.

Controlling costs associated with the operation of ICP-OES instruments is a continuing challenge for laboratories, regardless of application, given the variety of operational, maintenance and hidden expenses that dramatically increase their total cost of ownership.

Traditional spectrometers bear the burden of a number of inherent problems in their design. A new whitepaper, titled “How New Spectrometer Technologies Substantially Cut Operating Costs,” explores how engineering innovations have addressed design issues to enable significant savings while improving performance. The advancements, detailed in the paper, include:

New system designs that deliver improved uptime and throughput while reducing operating costs.

A unique sealed optical system that abolishes the need for the constant purging of argon or nitrogen, eliminating purge gas consumables cost and purging delays.

Improved spectrometer technology that removes the need for a separate, external, water-based cooling system along with the associated purchase, installation, power and maintenance costs.

Innovations in optical technology that improve performance measures such as sensitivity and stability.

A robust generator design that provides ample power reserves, so it can handle extreme plasma loads, and adapt to quickly changing demands.

The paper is authored by SPECTRO Analytical Instruments, a leading global supplier of analytical instruments for optical emission and X-ray fluorescence spectrometry.

About SPECTRO:

SPECTRO, a unit of the Materials Analysis Division of AMETEK, Inc., manufactures advanced instruments, develops the best solutions for elemental analysis for a broad range of applications, and provides exemplary customer service.
SPECTRO’s products are known for their superior technical capabilities that deliver measureable benefits to the customer. From its foundation in 1979 until today, more than 30,000 analytical instruments have been delivered to customers around the world.

AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical products with over 15,000 colleagues at more than 120 manufacturing and sales and service operations in the United States and 30 other countries around the world.

NOVI, MICHIGAN, USA, — July 8, 2014 — New Federal regulations governing lead content tightening safety restrictions dictate much lower lead content for certain potable water systems and components than in the past. A new whitepaper explains the new lead-free water system regulations for OEMs and contractors — and how to specify valves to comply. It is available to download at https://www.ascovalvenet.com/pdf/LiteratureRequest/Lead_Free_White_Paper.pdf.

Manufacturers of potable water equipment and systems — including drinking water fountains, R/O (reverse osmosis) systems, coffee machines, and commercial kitchen equipment — as well as equipment maintenance contractors are affected. Many in the industry remain uncertain how the new lead-free water regulations will impact their manufacturing and purchasing.

The new paper outlines relevant sections of the new lead-free regulations, and then focuses on the choices facing specifiers and purchasers who need to select important components of the affected potable water equipment — two-way solenoid valves — to comply. The paper also considers the calculations that must be made to determine average lead content. Finally, it discusses the pros and cons of common valve materials (brass, composite/plastic, stainless steel, and lead-free brass), as well as other selection advantages for use in potable water systems.

ASCO Numatics, an Emerson company, offers comprehensive fluid automation solutions, including fluid control and fluid power products, for a wide range of industry-focused applications. The ASCO Numatics product line in North America consists of more than 50,000 valves, an extensive selection of air preparation equipment, and a full line of actuation products. ASCO products include solenoid pilot valves, angle body piston valves, linear indicators, redundant control systems, and pressure sensors. The Numatics line covers valve manifolds, cylinders, grippers, filters, regulators, and lubricators. For more information about ASCO Numatics products, visit www.asconumatics.com.

About Emerson and Emerson Industrial Automation

Emerson (www.Emerson.com) is a global leader in bringing technology and engineering together to provide innovative solutions for customers in industrial, commercial, and consumer markets around the world. The company is comprised of five business segments: Process Management, Industrial Automation, Network Power, Climate Technologies, and Commercial & Residential Solutions. Sales in fiscal 2013 were $24.7 billion. Emerson Industrial Automation (www.EmersonIndustrial.com), a business of Emerson, provides automation and power generation technologies and services to a wide range of industries. With its global capabilities and deep industry expertise, Emerson Industrial Automation is a trusted partner for products and solutions that increase machine performance, efficiency, reliability, and availability. Its industry-leading brands include Appleton®, ASCO®, Branson®, Browning®, Control Techniques, Kop-Flex®, Leroy-Somer®, McGill®, Morse®, Numatics®, O-Z/Gedney, Rollway®, SealMaster®, and System Plast™.

AGAWAM, MASS. — October 22, 2013 —The use of stability testing in new product development — of drug substances, drug products, combination products and some medical devices — is reviewed in a new whitepaper from Microtest Laboratories, a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries.

Stability studies can help determine formulation and manufacturing strategy, analytical assay development and validation — and help explain unexpected and failing results. They can also provide input to manufacturing controls, and help identify final packaging requirements. The paper examines three specialized stability studies as examples:

Forced degradation studies, which involve exposing the product to predetermined stress conditions in order to intentionally form likely degradation products;

Photostability testing, used to determine the product’s ability to withstand exposure to light without any adverse effects;

Temperature cycling studies, used to assess the impact of temperature changes on the product.

Two case studies, one involving a drug product and one a combination product, are also presented.

The use of stability studies in the development of new drug or combination products can ease both the planning and execution of a development strategy. Moreover, the studies may also help prevent unnecessary costs and time delays due to poor formulations, assay failures, and manufacturing problems.

Microtest Laboratories is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, USA, the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680.

Combination products are a large and growing segment of the medical device market. Some analysts estimate they represent over 30% of all new FDA product submissions.

“Over the last 10 years, FDA regulatory centers have struggled with the changes and challenges that these new technologies present. For manufacturers, the convergence of drugs, biologics, and devices has created both a host of regulatory issues — and many exciting opportunities,” according to Steven Richter, Ph.D, President and Chief Scientific Officer of Microtest Laboratories, Inc., and author of the new white paper.

The new FDA publication, “21 CFR Part 4 — Current Good Manufacturing Practice Requirements for Combination Products,” revises regulations by establishing different categories of products. These included single-entity products (such as a drug-eluting stent) and co-packaged products (such as a packaged syringe and pharmaceutical). The rules also distinguished between a drug with a device, a biologic with a device, and a device with an HCT/P.

The new white paper discusses, in detail and example, how the new FDA rules guide a manufacturer into one of two approaches, depending upon the characteristics of their product.

According to Dr. Richter, “the FDA’s new streamlined approach for regulating combination products is a big step forward for the practitioner. It applies parts of both the QSR and GMP quality systems in a way that makes sense for the unique characteristics of each combination product. 21 CFR Part 4 closes the gaps in the 2004 guidelines and succinctly clarifies the process for establishing quality systems that ensure compliance and patient health and safety.”

Based in Agawam, Mass., the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information about Microtest Laboratories, visit microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680. Follow Microtest Laboratories on Twitter @MicrotestLabs at http://twitter.com/MicrotestLabs.

“The FDA requires all compounding pharmacies to comply with USP section <797>, which outlines the different standards and regulations for environmental control, testing, and personnel training. Currently, the operations of large-scale compounders do not fall under the scrutiny and regulation of the FDA. However, these facilities may now face inspections from both the state regulatory authorities and the federal government,” said white paper author Steven Richter, Ph.D., president and scientific director of Microtest Laboratories — and a former FDA official.

In the white paper, Dr. Richter advises compounding pharmacies on the critical issues to resolve prior to an FDA or state inspection, including sterile compounding regulations, quality testing, sterility testing of compounded articles, disinfectant validations, and endotoxin testing.

“In the aftermath of the NECC case, FDA and state actions regarding compounding pharmacies are relatively certain: regulations and inspections will both tighten and increase. The FDA, in some instances, will assume the role of lead auditor for the compounding pharmacy’s operations,” Dr. Richter said. “It is critical for compounding pharmacies to maintain a state of control in their controlled environments. While there may always be excursions, it is the actions that are undertaken after the excursions that will influence an inspector’s responses and observations during an on-site investigation and inspection.”

Microtest Laboratories is a Massachusetts-based, FDA-audited company with a history of exceptional regulatory compliance. Microtest Labs’ environmental sciences group helps clients maintain control of their controlled environments and is a proven resource for contamination testing needs arising from the manufacturing of medical devices or pharmaceuticals, as well as sterile compounding in hospital pharmacies.

About Microtest Laboratories

Microtest Laboratories is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, USA, the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free at 1-800-631-1680. Follow Microtest Laboratories on Twitter @MicrotestLabs at http://twitter.com/MicrotestLabs.

FLORHAM PARK, N.J. — March 5, 2012 — The evaluation and selection of stainless steel pilot valves — which play small but critical roles in the control of offshore platforms and other demanding oil and gas production operations — is the subject of a new white paper available for download at http://goo.gl/U3BgC.

Titled “Eight Critical Factors in Purchasing Offshore Pilot Valves,” the white paper guides panel builders, assemblers, OEMs, contractors, and operators as they consider the factors that bear on a given design’s reliability. The valves, which act as pilots for process and larger emergency shutdown (ESD) valves, are typically installed in a platform’s pneumatic logic control panels.

The April 2010 platform loss and oil spill in the Gulf of Mexico have dramatically sharpened the industry’s focus on reliability and related issues. In the case of pilot valves, this means that operators must have robust valves that perform efficiently each time, every time.

The white paper considers several problems that interfere with the efficient, reliable performance of conventional pilot valves in offshore use. It also highlights design changes that have addressed these problems in newer models.

ASCO Numatics, a division of Emerson, offers comprehensive fluid automation solutions, including fluid control and fluid power products, for a wide range of industry-focused applications. The ASCO Numatics product line in North America consists of more than 50,000 valves, an extensive selection of air preparation equipment, and a full line of actuation products. ASCO products include solenoid pilot valves, angle body piston valves, linear indicators, redundant control systems, and pressure sensors. The Numatics line covers valve manifolds, cylinders, grippers, filters, regulators, and lubricators. For more information about ASCO Numatics products, visit www.asconumatics.com

About Emerson

Emerson (NYSE: EMR), based in St. Louis, Missouri (USA), is a global leader in bringing technology and engineering together to provide innovative solutions for customers in industrial, commercial, and consumer markets around the world. The company is comprised of five business segments: Process Management, Industrial Automation, Network Power, Climate Technologies, and Commercial & Residential Solutions. Sales in fiscal 2011 were $24.2 billion. For more information, visit www.Emerson.com.

Fuel gas shutoff valves represent the main line of defense in combustion devices such as burners and boilers. They’re key to the safe operation of equipment for nonresidential comfort heating, commercial and industrial heating, and power and steam generation applications worldwide.

Tapping the expertise of valve manufacturing insiders, “The Insiders’ Guide to Modular Gas Valves” reveals how original equipment manufacturers (OEMs) and end users alike can take maximum advantage of these new factors. In it, authors Gerry Longinetti, Marketing Manager, ASCO and James Chiu, Marketing Product Engineer, ASCO, offer useful guidance in choosing the right valve for a variety of vital applications.

ASCO Numatics, an Emerson company, offers comprehensive fluid automation solutions, including fluid control and fluid power products, for a wide range of industry-focused applications. The ASCO Numatics product line in North America consists of more than 50,000 valves, an extensive selection of air preparation equipment, and a full line of actuation products. ASCO products include solenoid pilot valves, angle body piston valves, linear indicators, redundant control systems, and pressure sensors. The Numatics line covers valve manifolds, cylinders, grippers, filters, regulators, and lubricators. For more information about ASCO Numatics products, visit http://www.asconumatics.com.

About Emerson

Emerson (NYSE: EMR), based in St. Louis, Missouri (USA), is a global leader in bringing technology and engineering together to provide innovative solutions for customers in industrial, commercial, and consumer markets through its network power, process management, industrial automation, climate technologies, and tools and storage businesses. Sales in fiscal 2011 were $24.2 billion. For more information, visit www.Emerson.com.

“Cleaning validation for reusable medical devices is an important step in proving their safety. Available guidance documents now indicate that the traditional method of validating cleanliness, spore log reduction, will no longer be acceptable. Analytical assays capable of providing quantitative results will now be required instead,” writes white paper author Patrick Kenny, Manager of Analytical Services, Microtest Laboratories.

“An effective protocol and report that includes justifications for the test soil and assays chosen, as well as thorough documentation of all parameters used in the validation, will help ensure success for the device’s submission,” he notes.

In the paper, Kenny also discusses cleaning validation analytical assays as well as various methods and scenarios related to performing the validation. His recommendations are based on several key documents relating to reusable device cleaning validations that are either in draft or final form. They include AAMI document TIR30:2003, a comprehensive guide to medical device cleaning validations. TIR30 is currently in revision, and an updated version is scheduled for 2011 release.

Kenny holds a M.S. degree in Chemistry and has spent the past 13 years working in QC, R&D and manufacturing laboratories. At Microtest, Kenny leads the services group performing medical device and pharmaceutical analytical testing for companies worldwide.

Microtest Laboratories is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, U.S.A., the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680. Follow Microtest Laboratories on Twitter @MicrotestLabs at http://twitter.com/MicrotestLabs.

“Equipment designers frequently must incorporate miniature solenoid valves into their pneumatic designs. These valves are important components of medical devices and instrumentation as well as environmental, analytical, and similar product applications,” said white paper author Mike Elsigian, marketing manager, ASCO Valve, Inc.

In the white paper, Elsigian defines which requirements are critical for common applications. He details how the selection of miniature solenoid valves for the design of a given device usually involves finely balancing tradeoffs among competing pressures for reliability, service life, light weight, higher flow, optimized power use, standards compliance, and more.

Elsigian also highlights the introduction of newer valve technologies that can lessen or eliminate difficult compromises — while increasing performance. “New miniature solenoid valve technologies represent the fusion of several innovative approaches to meet the widest possible range of demands from knowledgeable designers across multiple industries,” he said.

“All too often, these designers find themselves frustrated as they face compromise after compromise. Pressure for increasingly miniaturized devices complicates every step of the design and valve selection process. And missteps can wreak havoc,” he said. “We’re hoping that the expertise we provide will assist designers in achieving the balance they need for success among the variety of often-contradictory performance requirements demanded by their applications.”

Emerson Industrial Automation, a business of Emerson, delivers manufacturing solutions designed with leading technologies — including mechanical, electrical and ultrasonic — to provide the most advanced industrial automation possible for numerous and diverse industries worldwide. The company’s wide range of products and systems used in manufacturing processes and other equipment includes motion control systems, plastics joining, precision cleaning, materials-testing equipment, fluid control valves, alternators, motors, and mechanical power transmission drives and bearings. For information, visit www.emersonindustrialautomation.com.

About Emerson

Emerson (NYSE: EMR), based in St. Louis, Missouri (USA), is a global leader in bringing technology and engineering together to provide innovative solutions for customers in industrial, commercial, and consumer markets through its network power, process management, industrial automation, climate technologies, and tools and storage businesses. Sales in fiscal 2010 were $21 billion. For more information, visit www.Emerson.com.

About Tiziani Whitmyre

Tiziani Whitmyre Inc.'s public relations expertise is in technology & life sciences PR. We work with companies from small business startups to global leaders. Unlike traditional firms, we are very flexible in our PR services and combine the expertise of large agency professional talent within the flexibility of a boutique. We help clients generate sales leads, launch new products, enter new markets, establish technical leadership, and achieve other business goals. We craft and execute cost-effective, results-focused efforts that integrate traditional and Web 2.0 solutions as discrete projects, targeted campaigns, on-going PR programs, or elements in an integrated marketing program. Our industry experience is deep and includes analytical instruments, biotechnology, ecommerce, food and dairy, healthcare, high technology, laboratory sciences, life sciences, machinery, manufacturing, medical products, pharmaceuticals, professional services, and software